Amgen patents declared valid, despite Sanofi challenge

18-03-2016

Amgen patents declared valid, despite Sanofi challenge

Green Apple / Shutterstock.com

A US court has ruled that two patents covering the Repatha (evolocumab) drug, owned by biotechnology company Amgen, are valid.


Amgen; Regeneron; Sanofi; Repatha; Praluent; US Food and Drug Administration

LSIPR